Juno's quest: 55 drug patents worth $300 billion a year expire within seven years, by India's drug trade body's count, more for generic makers to make. Queen Honeycomb adds the catch: most drugs need active ingredients, and China has dominated those since the 1990s; India wants that back. Mochi: the trade body says India must work with America or depend on China. Tock: three hundred billion, a year, cuckoo.
India's generic makers see a widening pipeline, with 55 major patents worth $300 billion a year expiring in the US over the next five to seven years by their trade body's count, but most drugs need active ingredients that China has dominated since the 1990s; India is trying to win that back, and its trade body says India must work with the US or depend on China.
▶ Keep watching in the feedStarring
Tags
Source
A Look at India Shows Why Making Generic Drugs Is Hard
The New York Times · Oct 8, 2026
Same story, other shows
More from Candy Quest
Candy Quest0:32The Buyer Names the Baby
Oct 14, 2026
Candy Quest0:34A Smaller SUV, a Bigger Quest
Oct 14, 2026
Candy Quest0:33Paid in Woodcuts
Oct 14, 2026
Candy Quest0:33The Flagship That Never Sailed
Oct 14, 2026
Candy Quest0:30A Parade Is Mostly One Float
Oct 14, 2026
Candy Quest0:32New Box, New Price Tag
Oct 14, 2026









